GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Capex-to-Operating-Income

Vilin Bio Med (NSE:VILINBIO) Capex-to-Operating-Income : 0.00 (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Vilin Bio Med's Capital Expenditure for the six months ended in Sep. 2023 was ₹0.00 Mil. Its Operating Income for the six months ended in Sep. 2023 was ₹13.13 Mil.

Hence, Vilin Bio Med's Capex-to-Operating-Income for the six months ended in Sep. 2023 was 0.00.


Vilin Bio Med Capex-to-Operating-Income Historical Data

The historical data trend for Vilin Bio Med's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med Capex-to-Operating-Income Chart

Vilin Bio Med Annual Data
Trend Mar20 Mar21 Mar22
Capex-to-Operating-Income
0.04 - -

Vilin Bio Med Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Sep23
Capex-to-Operating-Income - - - - -

Competitive Comparison of Vilin Bio Med's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Vilin Bio Med's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vilin Bio Med's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vilin Bio Med's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Vilin Bio Med's Capex-to-Operating-Income falls into.



Vilin Bio Med Capex-to-Operating-Income Calculation

Vilin Bio Med's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2022 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / 5.463
=0.00

Vilin Bio Med's Capex-to-Operating-Income for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / 13.127
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vilin Bio Med  (NSE:VILINBIO) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Vilin Bio Med Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Vilin Bio Med (NSE:VILINBIO) Business Description

Traded in Other Exchanges
N/A
Address
Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009
Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines